Brief: Incannex Healthcare Completes Positive Pre-IND Meeting With US FDA On IHL-675A
26/07/2023 24:40
July 26 (Reuters) - Incannex Healthcare Ltd IHL.AX :
* COMPLETES POSITIVE PRE-IND MEETING WITH US FDA ON IHL-675A
FOR
TREATMENT OF RHEUMATOID ARTHRITIS
Source text for Eikon: ID:nASX57P1B8
Further company coverage: IHL.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Incannex Healthcare
See all newsBrief: Incannex Healthcare Says Computershare To Be Appointed As US Transfer Agent
Brief: Incannex Healthcare Says Federal Court Of Australia Approved Proposed Schemes Of Arrangement Between Incannex And Its Shareholders
Australia's Incannex up as shareholders in favour of US redomicile
Brief: Incannex Healthcare Will Prepare FDA Ind Application PSI-Gad
Brief: Review Of Ind Application For Ihl-42X By Us FDA Has Been Completed Clinical Trial For Patients With Obstructive Sleep Apnoea May Proceed